Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Mallinckrodt
Boehringer Ingelheim
Baxter
AstraZeneca

Last Updated: October 1, 2022

Litigation Details for LEO Pharma A/S v. Taro Pharmaceuticals U.S.A. (D. Del. 2019)


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Small Molecule Drugs cited in LEO Pharma A/S v. Taro Pharmaceuticals U.S.A.
The small molecule drug covered by the patents cited in this case is See Plans and Pricing .
Biologic Drugs cited in LEO Pharma A/S v. Taro Pharmaceuticals U.S.A.
The biologic drug covered by the patents cited in this case is See Plans and Pricing .

Details for LEO Pharma A/S v. Taro Pharmaceuticals U.S.A. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-07-30 31 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,322,085 . (Blumenfeld, Jack…2019 27 March 2020 1:19-cv-00221 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-01-31 4 B2 ;8,900,554 B2 ;9,211,259 B2; 9,265,725 B2; 10,117,812 B2 (rwc) Modified on 3/27/2019 (fms). (Entered… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,700,076 B2 ;…2019 27 March 2020 1:19-cv-00221 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-03-27 54 Patent/Trademark Report to Commissioner of Patents B2 ;8,900,554 B2 ;9,211,259 B2; 9,265,725 B2; 10,117,812 B2; 10,332,085. (Attachments: # 1 Stipulated … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,700,076 B2 ;…2019 27 March 2020 1:19-cv-00221 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Express Scripts
McKinsey
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.